demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
ivermectin Galan Galan

3 studies excluded by filtering options 0

6095 Camprubi, 2020 1110not a RCTrisk of bias not avaialble
6368 Niaee (vs placebo), 2020 213excludedhigh risk of bias
6449 Okumuş, 2020 113high risk of bias